421 related articles for article (PubMed ID: 17568677)
1. Systemic antihypertensive medication and incident open-angle glaucoma.
Müskens RP; de Voogd S; Wolfs RC; Witteman JC; Hofman A; de Jong PT; Stricker BH; Jansonius NM
Ophthalmology; 2007 Dec; 114(12):2221-6. PubMed ID: 17568677
[TBL] [Abstract][Full Text] [Related]
2. Associations between elevated intraocular pressure and glaucoma, use of glaucoma medications, and 5-year incident cataract: the Blue Mountains Eye Study.
Chandrasekaran S; Cumming RG; Rochtchina E; Mitchell P
Ophthalmology; 2006 Mar; 113(3):417-24. PubMed ID: 16458969
[TBL] [Abstract][Full Text] [Related]
3. Incidence of glaucomatous visual field loss: a ten-year follow-up from the Rotterdam Study.
Czudowska MA; Ramdas WD; Wolfs RC; Hofman A; De Jong PT; Vingerling JR; Jansonius NM
Ophthalmology; 2010 Sep; 117(9):1705-12. PubMed ID: 20591487
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic medication and incident open-angle glaucoma.
Marcus MW; Müskens RP; Ramdas WD; Wolfs RC; de Jong PT; Vingerling JR; Hofman A; Stricker BH; Jansonius NM
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3801-5. PubMed ID: 22589449
[TBL] [Abstract][Full Text] [Related]
5. Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study.
Miglior S; Torri V; Zeyen T; Pfeiffer N; Vaz JC; Adamsons I;
Am J Ophthalmol; 2007 Aug; 144(2):266-275. PubMed ID: 17543874
[TBL] [Abstract][Full Text] [Related]
6. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.
Iskedjian M; Walker JH; Desjardins O; Robin AL; Covert DW; Bergamini MV; Einarson TR
Curr Med Res Opin; 2009 Aug; 25(8):1879-88. PubMed ID: 19530975
[TBL] [Abstract][Full Text] [Related]
7. Incidence of open-angle glaucoma in a general elderly population: the Rotterdam Study.
de Voogd S; Ikram MK; Wolfs RC; Jansonius NM; Hofman A; de Jong PT
Ophthalmology; 2005 Sep; 112(9):1487-93. PubMed ID: 16039716
[TBL] [Abstract][Full Text] [Related]
8. Rates of glaucoma medication utilization among persons with primary open-angle glaucoma, 1992 to 2002.
Stein JD; Ayyagari P; Sloan FA; Lee PP
Ophthalmology; 2008 Aug; 115(8):1315-9, 1319.e1. PubMed ID: 18321581
[TBL] [Abstract][Full Text] [Related]
9. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
Martínez A; Sánchez M
Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
[TBL] [Abstract][Full Text] [Related]
10. Persistence and adherence with topical glaucoma therapy.
Nordstrom BL; Friedman DS; Mozaffari E; Quigley HA; Walker AM
Am J Ophthalmol; 2005 Oct; 140(4):598-606. PubMed ID: 16226511
[TBL] [Abstract][Full Text] [Related]
11. Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents.
van Leeuwen R; Tomany SC; Wang JJ; Klein R; Mitchell P; Hofman A; Klein BE; Vingerling JR; Cumming RG; de Jong PT
Ophthalmology; 2004 Jun; 111(6):1169-75. PubMed ID: 15177967
[TBL] [Abstract][Full Text] [Related]
12. Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study.
Lee AJ; Wang JJ; Kifley A; Mitchell P
Ophthalmology; 2006 Jul; 113(7):1069-76. PubMed ID: 16815396
[TBL] [Abstract][Full Text] [Related]
13. Is diabetes mellitus a risk factor for open-angle glaucoma? The Rotterdam Study.
de Voogd S; Ikram MK; Wolfs RC; Jansonius NM; Witteman JC; Hofman A; de Jong PT
Ophthalmology; 2006 Oct; 113(10):1827-31. PubMed ID: 16884777
[TBL] [Abstract][Full Text] [Related]
14. Retinal vessel diameters and incident open-angle glaucoma and optic disc changes: the Rotterdam study.
Ikram MK; de Voogd S; Wolfs RC; Hofman A; Breteler MM; Hubbard LD; de Jong PT
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1182-7. PubMed ID: 15790877
[TBL] [Abstract][Full Text] [Related]
15. Predictors of long-term progression in the early manifest glaucoma trial.
Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
[TBL] [Abstract][Full Text] [Related]
16. Incidence of open-angle glaucoma in central Sweden.
Ekström C
Acta Ophthalmol; 2008 Nov; 86(7):747-54. PubMed ID: 18785965
[TBL] [Abstract][Full Text] [Related]
17. Topical beta-blockers and mortality.
Müskens RP; Wolfs RC; Witteman JC; Hofman A; de Jong PT; Stricker BH; Jansonius NM
Ophthalmology; 2008 Nov; 115(11):2037-43. PubMed ID: 18801580
[TBL] [Abstract][Full Text] [Related]
18. Substance use disorder and the risk of open-angle glaucoma.
French DD; Margo CE; Harman LE
J Glaucoma; 2011 Sep; 20(7):452-7. PubMed ID: 21278592
[TBL] [Abstract][Full Text] [Related]
19. Use of antihypertensive medications and topical beta-blockers and the long-term incidence of cataract and cataract surgery.
Kanthan GL; Wang JJ; Rochtchina E; Mitchell P
Br J Ophthalmol; 2009 Sep; 93(9):1210-4. PubMed ID: 19628496
[TBL] [Abstract][Full Text] [Related]
20. Frequency of systemic vascular diseases in patients with primary open-angle glaucoma and exfoliation glaucoma.
Tarkkanen A; Reunanen A; Kivelä T
Acta Ophthalmol; 2008 Sep; 86(6):598-602. PubMed ID: 18435818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
